A new survey suggests many people with ALS would value even modest slowing of ALS progression as a treatment goal.
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the ...
- The Expanded Access Program is funded by a grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Accelerating Access to Critical Therapies for ALS (ACT for ALS) ...
Hosted on MSN
New Brain Tech Gives Voice to ALS Patients
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects muscle control, and most patients reach a point at which either the disease itself or a necessary ...
Columnist Juliet Taylor recalls how difficult it was for her to ask for help, until her late husband's ALS diagnosis changed everything.
Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Researchers have found that patients with amyotrophic lateral sclerosis have ...
A look at Amyotrophic Lateral Sclerosis (ALS), focusing on motor neuron degeneration, sporadic versus familial ...
COUNTY SHERIFF’S DEPARTMENT. WELL, IMAGINE HAVING A MEDICINE HELPING TO KEEP YOU ALIVE AND SUDDENLY IT IS GONE. WE’RE HEARING FROM A WOMAN LIVING WITH ALS OR LOU GEHRIG’S DISEASE, WHO SAYS SHE MAY BE ...
At 71 years old, facing a terminal diagnosis, Colorado resident Tom Pringle has one more thing he wants to do before he dies: ...
A simple non-invasive hair-based test could one day help with early diagnosis of amyotrophic lateral sclerosis (ALS)—improving patient care and potentially extending survival. This is the hope of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results